The preliminary work from Imperial assumes there will be a drop in vaccine efficacy against Omicron. Even with a booster, ...

The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

They are all descendants of the original Omicron strain, which is no longer circulating. Evidence suggests that FLiRT ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...